Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
LIDIA SZCZEPANIAK
🇵🇱
Poland
Country
🇵🇱
Poland
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Regression of Myocardial Steatosis by Nebivolol
Early Phase 1
Completed
Conditions
Cardiac Steatosis and Lipotoxicity
Interventions
Drug: Nebivolol
Subscribe
First Posted Date
2011-05-23
Last Posted Date
2017-07-14
Lead Sponsor
Lidia Szczepaniak
Target Recruit Count
31
Registration Number
NCT01358409
Locations
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy